Goletti D, Weissman D, Jackson R W, Graham N M, Vlahov D, Klein R S, Munsiff S S, Ortona L, Cauda R, Fauci A S
Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
J Immunol. 1996 Aug 1;157(3):1271-8.
The prevalence of Mycobacterium tuberculosis (MTB) has increased worldwide, in part due to the HIV epidemic. Epidemiology data have demonstrated that HIV-infected individuals are more susceptible to MTB disease, which may lead to an acceleration in the progression of HIV disease. The purpose of this study was to determine whether MTB modulates HIV infection in vivo and to delineate the mechanisms involved by using in vitro model systems. Plasma viral load was measured in HIV-infected individuals before, during, and after the development of MTB disease; a 5- to 160-fold increase in viral replication was observed during the acute phase of MTB disease. In order to evaluate the mechanisms involved in this MTB-induced HIV replication, we used an in vitro system of primary PBMC and lymph node mononuclear cells isolated from HIV-infected individuals. The data demonstrated that MTB induced HIV replication in CD8+ T cell-depleted lymphocytes from HIV-infected individuals with a history of purified protein derivative (PPD) positivity but not in those who were PPD negative; this induction of HIV replication correlated with the level of cellular activation. In an in vitro acute HIV infection model, MTB increased HIV replication in PBMC from healthy donors with a history of PPD positivity, but not in PBMC from PPD-negative donors and this induction of viral replication also correlated with cellular activation. In conclusion, MTB increased HIV replication in vivo and in an in vitro model. This MTB-mediated viral production likely occurs through Ag-specific activation and infection of responding T cells.
结核分枝杆菌(MTB)在全球的流行率有所上升,部分原因是艾滋病流行。流行病学数据表明,感染HIV的个体更容易患MTB疾病,这可能会加速HIV疾病的进展。本研究的目的是确定MTB在体内是否调节HIV感染,并通过体外模型系统描述其中涉及的机制。在MTB疾病发生之前、期间和之后,对感染HIV的个体测量血浆病毒载量;在MTB疾病急性期观察到病毒复制增加了5至160倍。为了评估MTB诱导HIV复制所涉及的机制,我们使用了从感染HIV的个体中分离出的原代外周血单核细胞(PBMC)和淋巴结单核细胞的体外系统。数据表明,MTB在有纯化蛋白衍生物(PPD)阳性史的感染HIV个体的CD8 + T细胞耗竭淋巴细胞中诱导HIV复制,但在PPD阴性个体中则不然;这种HIV复制的诱导与细胞活化水平相关。在体外急性HIV感染模型中,MTB增加了有PPD阳性史的健康供体PBMC中的HIV复制,但在PPD阴性供体的PBMC中则不然,这种病毒复制的诱导也与细胞活化相关。总之,MTB在体内和体外模型中均增加了HIV复制。这种MTB介导的病毒产生可能是通过抗原特异性激活和应答T细胞感染而发生的。